MED12L

Chr 3AD

mediator complex subunit 12L

Also known as: NIZIDS, NOPAR, TNRC11L, TRALP, TRALPUSH

The protein is a component of the Mediator complex that functions as a coactivator for RNA polymerase II-dependent gene transcription by bridging gene-specific regulatory proteins with the basal transcription machinery. Mutations cause Nizon-Isidor syndrome with autosomal dominant inheritance. This gene is extremely intolerant to loss-of-function variants, indicating that proper protein dosage is critical for normal development.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismADLOEUF 0.181 OMIM phenotype
Clinical SummaryMED12L
🧬
Gene-Disease Validity (ClinGen)
Nizon-Isidor syndrome · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 228 VUS of 300 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.18LOEUF
pLI 1.000
Z-score 9.13
OE 0.12 (0.080.18)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
3.13Z-score
OE missense 0.74 (0.700.79)
869 obs / 1170.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.12 (0.080.18)
00.351.4
Missense OE0.74 (0.700.79)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 15 / 125.2Missense obs/exp: 869 / 1170.5Syn Z: -0.46
DN
0.2997th %ile
GOF
0.2597th %ile
LOF
0.83top 5%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 77% of P/LP variants are LoF · LOEUF 0.18

Literature Evidence

LOFOverall data suggest that MED12L haploinsufficiency is responsible for intellectual disability and transcriptional defect.PMID:31155615

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

300 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic11
VUS228
Likely Benign53
Benign3
Conflicting3
2
Pathogenic
11
Likely Pathogenic
228
VUS
53
Likely Benign
3
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
0
1
0
2
Likely Pathogenic
9
1
1
0
11
VUS
1
218
8
1
228
Likely Benign
0
18
5
30
53
Benign
0
1
0
2
3
Conflicting
3
Total112381533300

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MED12L · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →